Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
ImmunoACT update17-02-2024
17-02-2024
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst/Investor Meeting on February 19,2024 and February 20,202413-02-2024
Accumulate Laurus Labs; target of Rs 424: KR Choksey
KR Choksey recommended accumulate rating on Laurus Labs with a target price of Rs 424 in its research report dated January 29, 2024.31-01-2024
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript for Q3 FY24 Earnings call hosted on January 24, 202430-01-2024
Buy Laurus Labs; target of Rs 440: Motilal Oswal
Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 440 in its research report dated January 25, 2024.29-01-2024
Laurus Labs, Slovenia's KrKa Ink Pact To Set Up JV Firm In Hyderabad
Laurus Labs on Thursday said it has inked a pact with Slovenia-based drug maker Krka to set up a joint venture firm in Hyderabad.25-01-2024
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
PRESS RELEASE25-01-2024
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Joint Venture
Laurus Labs enters into JV Agreement with KRKA25-01-2024
Laurus Labs Q3 Results Review - Operating Deleverage Drags Earnings: Motilal Oswal
Expect the business to recover from Q4 FY2425-01-2024
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Audio recording of the earnings call hosted on January 24, 202424-01-2024